If leukoencephalopathy is then detected, the algorithm suggests biochemical testing for metabolite excess in biofluids, followed by the sequencing of the TYMP gene, should an accumulation of thymidine and deoxyuridine be identified (Zimmer et al., 2014). The gene discussed is TYMP; the disease is Leukoencephalopathy.